FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200254768> ?p ?o ?g. }

• W4200254768 endingPage "2166.e1" @default.
• W4200254768 startingPage "2154" @default.
• W4200254768 abstract "Hereditary angioedema (HAE), most often caused by a genetically mediated deficiency in the activity of C1 inhibitor (C1INH) protein, is characterized clinically by recurrent episodes of localized swelling without wheals. HAE attacks can be painful, debilitating, and even fatal, resulting in physical discomfort, emotional stress, and interruptions of work, school, and/or social activities, all of which can affect health-related quality of life (HRQoL). Subcutaneous C1INH (C1INH[SC]) is recommended as a first-line option for long-term prophylaxis (LTP) in HAE. This narrative review provides a concise but comprehensive overview of all published data generated from the pivotal Phase III Clinical Study for Optimal Management of Preventing Angioedema With Low-Volume Subcutaneous C1-Inhibitor Replacement Therapy (COMPACT) study program, which evaluated the use of C1INH(SC) as LTP.A PubMed search was performed using the search terms subcutaneous C1 inhibitor plus COMPACT with no filters, and another search was performed using the term subcutaneous C1 inhibitor, with output limited to clinical trial data only. All publications that reported data generated during the Phase III COMPACT study were included. Data presentation focused on the US Food and Drug Administration-approved dose of 60 IU/kg.The search strategy identified a total of 11 publications that reported data and analyses from the Phase III COMPACT study. Publications reported overall findings from the double-blind, placebo-controlled, crossover COMPACT study and a subsequent long-term open-label extension (OLE) study. Other published analyses included pharmacokinetic/pharmacodynamic data, HRQoL assessments, and findings in patient subgroups including women, pediatric patients, and patients ≥65 years of age. Subgroup analyses reported good safety and efficacy profiles among age-based subgroups from the COMPACT OLE, including pediatric patients, patients ≥65 years of age with comorbidities, and among female patients, despite a tendency for HAE to be more severe in women. A number of significant HRQoL improvements were noted with C1INH(SC) use, including better overall health status, less anxiety, and less work- and activity-related impairment versus placebo (double-blind study), and compared with baseline (OLE).This review provides a concise overview of all published COMPACT study data with C1INH(SC). The data reviewed here portray a high level of efficacy and tolerability with C1INH(SC), even during periods of treatment that exceed 2 years, which does not appear to vary based on patient age or sex. Clinically relevant improvements in multiple facets of HRQoL were also reported, including better overall HRQoL, less anxiety and depression, and less disruptions in work attendance and productivity. These data should be useful for assessing the appropriateness of C1INH(SC) therapy for individual patients." @default.
• W4200254768 created "2021-12-31" @default.
• W4200254768 creator A5004962928 @default.
• W4200254768 creator A5088944933 @default.
• W4200254768 creator A5090720454 @default.
• W4200254768 date "2021-12-01" @default.
• W4200254768 modified "2023-09-23" @default.
• W4200254768 title "Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management" @default.
• W4200254768 cites W129442478 @default.
• W4200254768 cites W1967228366 @default.
• W4200254768 cites W1983267522 @default.
• W4200254768 cites W1987353096 @default.
• W4200254768 cites W1988555109 @default.
• W4200254768 cites W1988578052 @default.
• W4200254768 cites W1992040596 @default.
• W4200254768 cites W2012767544 @default.
• W4200254768 cites W2021010198 @default.
• W4200254768 cites W2031583523 @default.
• W4200254768 cites W2041540648 @default.
• W4200254768 cites W2044194498 @default.
• W4200254768 cites W2055547657 @default.
• W4200254768 cites W2066659148 @default.
• W4200254768 cites W2070603663 @default.
• W4200254768 cites W2086325363 @default.
• W4200254768 cites W2098192722 @default.
• W4200254768 cites W2103739302 @default.
• W4200254768 cites W2118852493 @default.
• W4200254768 cites W2121788941 @default.
• W4200254768 cites W2161476638 @default.
• W4200254768 cites W2165383253 @default.
• W4200254768 cites W2166281097 @default.
• W4200254768 cites W2315636913 @default.
• W4200254768 cites W2318188974 @default.
• W4200254768 cites W2328418752 @default.
• W4200254768 cites W2410594812 @default.
• W4200254768 cites W2436637673 @default.
• W4200254768 cites W2504595494 @default.
• W4200254768 cites W2511731096 @default.
• W4200254768 cites W2518027570 @default.
• W4200254768 cites W2577986790 @default.
• W4200254768 cites W2591909181 @default.
• W4200254768 cites W2599824295 @default.
• W4200254768 cites W2623331963 @default.
• W4200254768 cites W2742981589 @default.
• W4200254768 cites W2782841460 @default.
• W4200254768 cites W2788038611 @default.
• W4200254768 cites W2794946542 @default.
• W4200254768 cites W2821745872 @default.
• W4200254768 cites W2886386212 @default.
• W4200254768 cites W2910468637 @default.
• W4200254768 cites W2913393208 @default.
• W4200254768 cites W2946022223 @default.
• W4200254768 cites W2970162264 @default.
• W4200254768 cites W3000608103 @default.
• W4200254768 cites W3005702055 @default.
• W4200254768 cites W3026657539 @default.
• W4200254768 cites W3035373195 @default.
• W4200254768 cites W3083179120 @default.
• W4200254768 cites W3087080946 @default.
• W4200254768 cites W3096856827 @default.
• W4200254768 cites W3107108435 @default.
• W4200254768 cites W3121164637 @default.
• W4200254768 cites W3132855026 @default.
• W4200254768 cites W4246423891 @default.
• W4200254768 cites W50187013 @default.
• W4200254768 doi "https://doi.org/10.1016/j.clinthera.2021.10.008" @default.
• W4200254768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34879971" @default.
• W4200254768 hasPublicationYear "2021" @default.
• W4200254768 type Work @default.
• W4200254768 citedByCount "3" @default.
• W4200254768 countsByYear W42002547682022 @default.
• W4200254768 countsByYear W42002547682023 @default.
• W4200254768 crossrefType "journal-article" @default.
• W4200254768 hasAuthorship W4200254768A5004962928 @default.
• W4200254768 hasAuthorship W4200254768A5088944933 @default.
• W4200254768 hasAuthorship W4200254768A5090720454 @default.
• W4200254768 hasBestOaLocation W42002547681 @default.
• W4200254768 hasConcept C126322002 @default.
• W4200254768 hasConcept C141071460 @default.
• W4200254768 hasConcept C142724271 @default.
• W4200254768 hasConcept C159110408 @default.
• W4200254768 hasConcept C16005928 @default.
• W4200254768 hasConcept C187212893 @default.
• W4200254768 hasConcept C204787440 @default.
• W4200254768 hasConcept C27081682 @default.
• W4200254768 hasConcept C2776390293 @default.
• W4200254768 hasConcept C2777788586 @default.
• W4200254768 hasConcept C2777995640 @default.
• W4200254768 hasConcept C2779121184 @default.
• W4200254768 hasConcept C2779931649 @default.
• W4200254768 hasConcept C2779951463 @default.
• W4200254768 hasConcept C535046627 @default.
• W4200254768 hasConcept C71924100 @default.
• W4200254768 hasConceptScore W4200254768C126322002 @default.
• W4200254768 hasConceptScore W4200254768C141071460 @default.
• W4200254768 hasConceptScore W4200254768C142724271 @default.
• W4200254768 hasConceptScore W4200254768C159110408 @default.
• W4200254768 hasConceptScore W4200254768C16005928 @default.

• next